GXI.VI is trading at €26.74, down 5.38% as concerns over earnings visibility and profitability outlook continue to weigh on the pharmaceutical packaging company.
- The stock has experienced a sharp decline over the past week, falling from €28.38 on May 11 to its current level.
- Recent profit warnings and significant price target cuts from analysts have fueled investor anxiety regarding the company's financial trajectory.
- Today's session marks a continuation of recent weakness, reflecting broader market skepticism toward the firm's near-term growth prospects.